BioSpecifics Technologies Corporation
35 Wilbur Street
Lynbrook
New York
11563-2358
United States
Tel: 516-593-7000
Fax: 516-593-7010
Website: http://www.biospecifics.com/
219 articles about BioSpecifics Technologies Corporation
-
BioSpecifics Technologies Corporation to Host Conference Call to Report Second Quarter 2009 Financial Results on August 12, 2009
8/5/2009
-
BioSpecifics Technologies Corporation to Present at CapStone Investments' Third Annual Small-Cap Investor Conference
7/23/2009
-
BioSpecifics Technologies Corporation Added to Russell 3000 and Russell 2000 Indexes
6/30/2009
-
BioSpecifics Technologies Corporation Reports First Quarter 2009 Financial Results
5/11/2009
-
BioSpecifics Technologies Corporation Announces FDA Acceptance of Biologics License Application With Priority Review for XIAFLEX(TM) for the Treatment of Dupuytren's Disease
4/29/2009
-
BioSpecifics Technologies Corporation Reports Fourth Quarter and Full Year 2008 Financial Results
3/31/2009
-
BioSpecifics Technologies Corporation Announces Listing on NASDAQ Global Market
1/7/2009
-
Pfizer Inc. (JOBS) Buys Rights to Market Auxilium Pharmaceuticals's Key Drug; $410 Million in Potential Milestone Payments
12/18/2008
-
BioSpecifics Technologies Corporation to Present at Rodman & Renshaw 10th Annual Healthcare Conference
11/7/2008
-
BioSpecifics Technologies Corporation Announces Appointment of Dr. Matthew Geller to Board of Directors
9/25/2008
-
BioSpecifics Technologies Corporation Announces Initiation of Phase IIb Trial for Peyronie's Disease
9/17/2008
-
BioSpecifics Technologies Corporation Buys Down Royalties for Peyronie's Disease
9/5/2008
-
BioSpecifics Technologies Corporation Announces Private Placement Offering
8/25/2008
-
BioSpecifics Technologies Corporation Announces Additional Sales of Stock in Private Placement Offering
6/11/2008
-
BioSpecifics Technologies Corporation Announces Sale of Stock in Private Placement Offering
6/4/2008
-
BioSpecifics Technologies Corporation Announces Repayment of Outstanding Loan
2/6/2008
-
BioSpecifics Technologies Corporation Announces Sale of Stock in Private Placement Offering
1/15/2008
-
BioSpecifics Technologies Corporation Mourns Death Of Chairman And CEO Edwin H. Wegman
2/21/2007
-
Healthpoint Acquires Collagenase Topical Business From BioSpecifics Technologies Corporation
3/7/2006